SOHM, Inc. (SHMN)

OTCMKTS · Delayed Price · Currency is USD

0.0009

-0.0001 (-10.00%)

Mar 9, 2026, 1:19 PM EST

80.00% (1Y)

Market Cap	2.61M
Revenue (ttm)	1.30M
Net Income (ttm)	-1.13M
Shares Out	2.90B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100,000
Average Volume	759,555
Open	0.0010
Previous Close	0.0010
Day's Range	0.0009 - 0.0010
52-Week Range	0.0004 - 0.0021
Beta	0.84
RSI	49.59
Earnings Date	n/a

About SOHM, Inc.

SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based i... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2005

Employees 145

Stock Exchange OTCMKTS

Ticker Symbol SHMN

Full Company Profile

Financial Performance

In 2012, SOHM, Inc.'s revenue was $1.30 million, a decrease of -3.27% compared to the previous year's $1.34 million. Losses were -$1.13 million, 106.1% more than in 2011.

Financial Statements

News

There is no news available yet.